Senores Pharmaceuticals Limited has informed the Exchange regarding revised intimation in respect of earlier intimation dated December 29, 2025 under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Senores Pharmaceuticals has submitted a revised intimation to the exchanges regarding a GST demand order it had disclosed on December 29, 2025. The company received a Demand Order in Form GST DRC-07 from the Office of the Deputy/Assistant Commissioner of CGST & Central Excise, Ahmedabad-North on December 26, 2025. The order confirms a tax demand of Rs. 24.84 lakh along with an equal penalty of Rs. 24.84 lakh, taking the total potential outflow to about Rs. 49.69 lakh. The demand relates to alleged non-reversal of excess Input Tax Credit and non-payment of IGST. The company is filing an appeal before the GST Commissioner (Appeals) and has stated that no material financial or operational impact is expected. BSE had sought reasons for the delay in initial disclosure, which the company has now explained by citing December 27–28, 2025 as non-working days.
The financial exposure is small (under Rs. 50 lakh) and the company believes it is not material to its financials or operations. Investors should view this as a routine tax dispute, though the revised filing and BSE's query on delay flag minor compliance lapses in timely disclosure.